Abstract
The TGF-β signaling pathway is highly conserved and plays crucial roles in the maintenance of tissue homoeostasis. At the cellular level, TGF-β effects are pleiotropic, regulating pluripotency and differentiation in development but maintaining homeostasis through cytostatic mechanisms in the mature epithelium. Because of the crucial role of TGF-β in controlling cellular programs regulating proliferation, differentiation, and tissue regeneration, deregulation of the pathway is commonly seen in disease, including cancer.
Canonical TGF-β signaling is initiated by ligand-induced oligomerization of the serine/threonine receptor kinase leading to the phosphorylation of intracellular SMAD signaling molecules. Activated SMADs then regulate hundreds of TGF-β target genes through their ability to activate specific transcription factors.
TGF-β signaling is strongly implicated in many aspects of cancer progression mainly functioning as a tumor suppressor in early stages of cancer development. This tumor-suppressive effect is eradicated in many cancers by inactivation or loss of TGF-β pathway components. However, other cancers progress with an intact TGF-β signaling pathway; here evasion of the tumor-suppressive effect occurs downstream of SMAD signaling. Our recent work has demonstrated that in breast cancer, this paradoxical role of TGF-β activity is not necessarily linked to the stage of breast cancer progression.
Because of the important roles of TGF-β signaling in cancer, it has become an increasingly interesting candidate for drug development. However, further understanding of the opposing roles of TGF-β signaling in different tumor types, the role of the tumor microenvironment, and the development of markers of TGF-β activity is crucial for treatment strategies to succeed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Huminiecki L, et al. Emergence, development and diversification of the TGF-β signalling pathway within the animal kingdom. BMC Evol Biol. 2009;9:28.
Mullen AC, et al. Master transcription factors determine cell-type-specific responses to TGF-β signaling. Cell. 2011;147:565–76.
Massagué J. TGFβ in cancer. Cell. 2008;134:215–30.
Massagué J. TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012;13:616–30.
Siegel PM, Massagué J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer. 2003;3:807–21.
Bruna, et al. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer. Nat Commun. 2012;3:1055.
Tufegdzic Vidakovic A, et al. Context-specific effects of TGF-β/SMAD3 in cancer are modulated by the epigenome. Cell Rep. 2015;13:2480–90.
Massagué J, et al. Smad transcription factors. Genes Dev. 2005;19:2783–810.
Miyazono K. TGF-β signaling by Smad proteins. Cytokine Growth Factor Rev. 2000;11:15–22.
Kretzschmar M, et al. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature. 1997;389:618–22.
Matsuura I, et al. Cyclin-dependent kinases regulate the antiproliferative function of SMADs. Nature. 2004;430:226–31.
Zhang YE. Non-Smad pathways in TGF-beta signalling. Cell Res. 2009;19:128–39.
Padua D, Massagué J. Roles of TGFβ in metastasis. Cell Res. 2009;19:89–102.
Bruna, et al. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell. 2007;11(2):147–60.
Neuzillet C, et al. Targeting the TGFβ pathway for cancer therapy. Pharmacol Ther. 2015;147:22–31.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Greenwood, W., Bruna, A. (2019). TGF-β and the SMAD Signaling Pathway in Carcinogenesis. In: Badve, S., Kumar, G. (eds) Predictive Biomarkers in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-95228-4_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-95228-4_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95227-7
Online ISBN: 978-3-319-95228-4
eBook Packages: MedicineMedicine (R0)